Related Experiment Video
Updated: Jul 11, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors
Sampath-Kumar Anandan1, John S Ward, Richard D Brokx
1EntreMed Inc., 101 College Street, Toronto Medical Discovery Tower, Toronto, Ontario, Canada M5G1L7. skumar@aretetherapeutics.com
Abstract:
We have designed and synthesized a series of structurally novel hydroxamic acid-based histone deacetylase (HDAC) inhibitors characterized by a zinc chelating head group attached directly to a thiazole ring. The thiazole ring connects to a piperazine spacer, which is capped with a sulfonamide group. These novel molecules potently inhibit an HDAC enzyme mixture derived from HeLa cervical carcinoma cells and show potent antiproliferative activity against the breast cancer cell line MCF7.
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Antiviral Nucleoside Inhibitors
Antihypertensive Drugs: Thiazide-Class Diuretics
Enzyme Inhibition
Inhibitors of Bacterial DNA Synthesis

